Month: February 2025

Researchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg-Kimmel Institute for Cancer Immunotherapy have developed a computer model to help scientists identify tumor-fighting immune cells in patients with lung cancer treated with immune checkpoint inhibitors…Read More

Ugandan officials are preparing to deploy a trial vaccine as part of efforts to stem an outbreak of Ebola in the capital, Kampala, a top health official said Sunday…Read More

Alcohol-related deaths increased 18% during the pandemic, as did hospitalizations related to alcohol use, according to new research in the Canadian Medical Association Journal…Read More

The risk of being admitted to the hospital with heart disease is twice as high the year after birth for mothers of twins compared to singleton births, according to research published in the European Heart Journal. The risk is even higher in mothers of twins who had a high blood pressure condition during pregnancy…Read More

The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin…Read More

MedPage Today) — “I am not anti-vaccine.” — Robert F. Kennedy Jr., President Donald Trump’s nominee for HHS secretary, attempting to allay Senators’ concerns about his anti-vaccine advocacy during a confirmation hearing. “It checks all of…Read More

MedPage Today) — AURORA, Colo. — A higher dose of aspirin offered no significant benefit as preeclampsia prevention in high-risk patients, although those with multifetal gestations may have seen some gains, according to the ASAPP trial. The…Read More

MedPage Today) — Here is a hard truth for those of us who are care providers: Americans are unsatisfied with the country’s healthcare system. It is not just about cost or lack of access. Gallup recently found only 44% of Americans think the quality…Read More

MedPage Today) — The FDA approved an oral combination of meloxicam and rizatriptan (Symbravo) to treat adults with acute migraine with or without aura, Axsome Therapeutics announced. Meloxicam is a COX-2 preferential non-steroidal anti-inflammatory…Read More

MedPage Today) — Though it was not possible to determine causality, a retrospective case series identified nine patients who developed ophthalmic complications during treatment with semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound…Read More